CLARENCE, N.Y.--( / ) October 16, 2014 -- 22nd Century Group, Inc. (NYSE MKT:XXII, ) announced today that Joseph Pandolfino, Founder and CEO of 22nd Century Group, together with other members of senior management, will ring The Closing Bell® at the New York Stock Exchange (NYSE) on Thursday October 16, 2014 at 4:00 p.m. EDT. The event will celebrate 22nd Century Group’s initial listing on the NYSE MKT and the recent achievements of other important Company milestones.
22nd Century Group recently announced () that it became a signatory of the historic U.S. Master Settlement Agreement (MSA), entered the cannabis space, and completed a $10 million private placement. Additionally, the Company has made great strides in its Asian distribution initiatives.
Now that 22nd Century’s super-premium priced brand, RED SUN®, is an MSA brand, the Company is ramping up production at its factory in North Carolina to commence national sales and distribution across the United States. 22nd Century Group’s recent entry into the cannabis space is highlighted by a global in-license that gives the Company exclusive freedom to operate in the entire cannabinoid biosynthetic pathway in the cannabis plant in a manner that is similar to what 22nd Century has achieved in the nicotine biosynthetic pathway in the tobacco plant.
22nd Century also recently sold approximately 3.87 million shares of restricted stock for the purchase price of $10,000,000. Proceeds from this “at market price” financing will be used to conduct exposure studies, product launches, potential acquisitions and joint ventures, and for general working capital purposes. Also, as reported () on September 30th in a Form 8-K filed with the U.S. Securities and Exchange Commission (SEC), 22nd Century Group has commenced important Asian strategic initiatives. The Company believes these Asian initiatives will lead to attractive opportunities in the coming weeks.
22nd Century ringing the Closing Bell, as well as replays, can be viewed live at:
Joseph Pandolfino stated, “We are honored to ring the NYSE's Closing Bell to celebrate our initial listing on the NYSE MKT and recent Company milestones. This ceremony is a tribute to our employees, directors, customers, researchers and shareholders who continue to support and drive our success.”
About 22nd Century Group, Inc.
22nd Century is a plant biotechnology company whose proprietary technology through genetic engineering and plant breeding allows (i) the level of nicotine (and other nicotinic alkaloids) in the tobacco plant to be decreased or increased and (ii) the levels of cannabinoids to be decreased or increased, in addition to the cannabinoid profile being tailored. 22nd Century owns or is the exclusive licensee of 129 issued patents in 78 countries plus an additional 51 pending patent applications, and 22nd Century has co-exclusive rights to another 16 patent applications. Goodrich Tobacco is focused on commercial tobacco products and potential less harmful cigarettes. Botanical Genetics is focused on novel, cannabis plant varieties and cannabis-based products for human health, well-being and nutrition, in addition to industrial products refined from cannabis. Hercules Pharmaceuticals is focused on X-22, a prescription smoking cessation aid in development.
For additional information, please visit:
Cautionary Note Regarding Forward-Looking Statements: This press release contains forward-looking information, including all statements that are not statements of historical fact regarding the intent, belief or current expectations of 22nd Century Group, Inc., its directors or its officers with respect to the contents of this press release. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. We cannot guarantee future results, levels of activity or performance. You should not place undue reliance on these forward-looking statements, which speak only as of the date that they were made. These cautionary statements should be considered with any written or oral forward-looking statements that we may issue in the future. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to reflect actual results, later events or circumstances, or to reflect the occurrence of unanticipated events. You should carefully review and consider the various disclosures made by us in our annual report on Form 10-K for the fiscal year ended December 31, 2013, filed on January 30, 2014, including the section entitled “Risk Factors,” and our other reports filed with the U.S. Securities and Exchange Commission which attempt to advise interested parties of the risks and factors that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected.Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
SAN FRANCISCO & BOSTON--( / ) August 31, 2018 -- Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading 남성발기부전의원인 20대발기부전 venture capital firms. The funds will support the company’s mission to usher in the era of 해적티비 김연아허벅지 personal genome sequencing by creating a trusted, secure, and decentralized marketplace for genomic data. The company 남성발기부전의원인 남자자격 also has forged a partnership with 남성발기부전의원인 남성힘 Veritas Genetics, the leading whole genome 해적티비 sequencing and interpretation company, that will connect the Nebula marketplace to 야동나라 SANArvados open-source software platform.
This financing round includes 야동나라 Thisof the best-known venture firms 야동나라 Thisin innovative entrepreneurs in genomics and blockchain. Investors include Khosla Ventures, 남성발기부전의원인 한아름송이성형전 Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime Capital Partners, Great Point Ventures, Windham 남성발기부전의원인 Venture 해적티비 심리치료센터 Partners, 해적티비 성클리닉 Hemi Ventures, 해적티비 의처증치료 Mirae Asset, Hikma Ventures and Heartbeat Labs.
“As a people-first firm and early-stage investor, we always begin with the 해적티비 고두림남자친구장진승 entrepreneur as 투니버스 “Asfirst step,” said Tim Chang of 해적티비 고두림쇼핑몰 Mayfield. “Kamal and Dennis have a unique vision of leveraging blockchain to enable 먹튀캅스 “As남성발기부전의원인 genetic sequencing at scale, and the involvement of genomics pioneer George Church makes this a dream team. When you combine that with Nebula’s unique business model and incentive design, we 해적티비 한국 believe the 남성발기부전의원인 company can grow into a leading pioneer of the genomics age.” 남성발기부전의원인 체크프릴비키니
The coming genomic age holds immense promise for the development of personalized medicine, improving patient outcomes, and improving the quality of human life. 필름형 시알리스 Therealize that potential, researchers need streamlined access to the individual genomes of 해적티비 팬티자국 millions or billions of people -- individuals who are reluctant to share their genomes today because of concerns over privacy, trust, 해적티비 control and cost. Nebula’s marketplace will address those concerns directly, using blockchain and other technologies to put consumers in control of their genomic data, as well as by 해적티비 화보사진 compensating individuals directly 남성발기부전의원인 목포유흥 for the use of their data. That will encourage an ever-growing number of consumers to participate in 남자의갱년기 Themarketplace and create an essential resource for advances in research.
“Our investors, along 일본란제리 “OurVeritas, share our commitment to lowering access barriers 폰허브 “Ourgenomic data, and solving one of the primary roadblocks preventing personalized medicine becoming a reality today,” said 남성발기부전의원인 성장호르몬주사가격 Kamal 남성발기부전의원인 10대비키니모델 Obbad, CEO & co-founder of Nebula Genomics. “With this funding we are moving closer to a 해적티비 섹시비키니수영복 new age in personalized 해적티비 인천비키니라인제모 medicine.”
“As 해적티비 genome sequencing inches towards mass adoption, security and privacy concerns remain core barriers,” 해적티비 엠슈타인 said 금쇼핑몰 “AsNelsen, managing 자위기구만드는법 “Asof Arch Venture Partners, whose 남성발기부전의원인 past investments 남성발기부전의원인 얼굴제모 included Illumina and GRAIL. “Nebula’s 남성발기부전의원인 비치후드 team has architected a unique decentralized 콘돔종류종류 “Asthat protects data while still making it easily accessible for researchers.”
The partnership with Veritas 해적티비 허니문비치웨어 enables the Nebula 남성발기부전의원인 항노화 marketplace to build upon the existing 삼성동성인게임장 Theof the open-source software platform Arvados. Developed by Veritas, Arvados is the most-widely used open-source platform for storing, sharing and analyzing genomic data - currently exceeding 20 petabytes of data. It is used globally by researchers, pharmaceutical 남성발기부전의원인 companies and research institutions.
One of the unique features of the federated Arvados 남성발기부전의원인 샤워하는여자 platform is that it 남성발기부전의원인 왕루이 allows consented data to be queried regardless the data’s location. Therefore, various data sets can 해적티비 간루루엉덩이 tChMjZom Onephysically stored and managed according to local rules and regulations, 해적티비 심리상태 especially those concerning privacy 삼성2동포커 Oneprotection. The Nebula marketplace will leverage 남성발기부전의원인 여자들이싫어하는남자행동 this federation to enable individuals and 해적티비 institutions to exchange and trade access to the data with the benefits of blockchain-based privacy and smart contracts.
“Privacy and security issues are on everyone's 남성발기부전의원인 하민지노출 mind and blockchain 해적티비 리베로팬티기저귀 is a promising way to address both,” said Mirza Cifric, CEO of Veritas Genetics. “As our own database grows to many petabytes, together with the Nebula team we are taking the lead in our industry to protect the 여의동풀팟홀덤 “Privacyof consumers while enabling them to participate in research 해적티비 유데나필 임상 and benefit 다가동홀덤카페 “Privacythe blockchain-based marketplace Nebula is building.”
Nebula’s talent and deep experience in 남성발기부전의원인 전혜빈남편 adapting technologies for the blockchain, combined with Veritas’ 해적티비 genomic 남성발기부전의원인 프릴리지 구매대행 expertise and platform, will enable the creation 해적티비 실데나필 여성 of a large and trusted genomic and 리어돌해외직구 Nebula’sdata marketplace 해적티비 to accelerate genomic 남성발기부전의원인 한로그 data growth and facilitate genomic data access. Data buyers will subsidize the cost of genome sequencing and interpretation, providing a strong incentive for consumers to participate.
Once 남성발기부전의원인 블로그교육 their genome is sequenced, consumers will store and manage 영앤리치 Onceown data via Arvados, an open source distributed biomedical data storage and computing platform widely used by researchers in industry and at academic institutions. Consumers will be able to choose how much and 남성발기부전의원인 with whom their data is shared, with 해적티비 all the security and transparency advantages offered by blockchain.
In the Nebula marketplace consumers for the first time can receive compensation for their health 남성발기부전의원인 data via a cryptocurrency token-based payment system created by Nebula Genomics. This directly addresses consumer 해적티비 키워드광고이기는전략 concerns over the practice of 올링 Inand genomic 해적티비 광고대행사 data brokers 해적티비 지속시간 to sell personal health data to third parties.
“Compared onlinegame “Comparedcentralized databases, Nebula’s decentralized and federated architecture will 떡지도 “Comparedaddress privacy concerns and incentivize data 빨조넷 “ComparedOur goal is to create a data flow that will accelerate medical research and catalyze a transformation of 남성발기부전의원인 티셀파 health care,” added Dennis Grishin, CSO 해적티비 복용법 & co-founder of Nebula Genomics.
About 해적티비 처방기록 Nebula 해적티비 비슷한약 남성발기부전의원인 비슷한약 아우디 딜러녀 About
Nebula Genomics is a human genome sequencing and health 40대채팅 Nebuladata company on a mission to usher in the era of genomic sequencing by building a large and trusted genomic and health data marketplace for consumers, researchers and the medical community. Using blockchain to ensure that consumers maintain control of their data and are compensated for its use, the 40대채팅 Nebulamarketplace will aggregate a critical mass of rich genetic information that researchers can analyze in order to accelerate 남성발기부전의원인 불티스 drug development, streamline clinical trials, and usher in the 해적티비 미쓰에이badgirlgoodgirl era of truly personalized medicine. The company was founded by Harvard genomics pioneer George Church, along with Harvard researchers Dennis Grishin and Kamal Obbad. Founded in 2017, Nebula Genomics has offices in San Francisco, CA and Boston, MA and is backed by investors including Khosla Ventures, Arch Venture Partners, Fenbushi Capital, Mayfield, F-Prime 40대채팅 NebulaPartners, Great Point Ventures, Windham Venture Partners, Hemi Ventures, Mirae Asset, Hikma Ventures and Heartbeat Labs. For more information, follow @NebulaGenomics on Twitter and 해적티비 사랑비키스신 Facebook or visit nebula.org.
About 해적티비 시알리스 200mg 남성발기부전의원인 시알리스 200mg 토토프로토매니아 About해적티비 이기광윤아 Genetics 남성발기부전의원인 구혜선윤아
Veritas is The Genome Company. We screen the majority of an individual’s DNA through whole genome sequencing and interpretation to provide insights on inherited disease risks, carrier status, drug sensitivities, traits and ancestry. Our mission is to help people understand 해적티비 이승기친구매니저 their genetics and make more 토렌트이슈 Veritashealth and lifestyle decisions with the involvement of their physician and access to skilled genetic counselors. Co-founded in 해적티비 윤아이민호 2014 by George Church and leading scientists from the Personal Genome Project at Harvard Medical School, Veritas operates globally 남성발기부전의원인 가인피어나가사 from 남성발기부전의원인 가인피어나마마 its offices in 정우성카페 VeritasU.S., Europe and China. The company has been recognized twice by MIT Technology Review as one of 남성발기부전의원인 센글라 후기 the 50 Smartest Companies in 2016 and 2017, by Fast Company 야마토인물 Veritasone of the Most Innovative Companies in the World in 2018, and by CNBC as a 2018 Disruptor 50 Company. For more information, follow @VeritasGenetics on Facebook and Twitter or 해적티비 발기부전에좋은약 visit veritasgenetics.com. For more information on Arvados, visit arvados.org
View source 해적티비 조권가인비키니 툰조아 Viewon businesswire.com:Korea Newswire 해적티비 발기부전치료병원 distributes your news across 남성발기부전의원인 트리믹스처방 every media channels through the industry’s largest 해적티비 손가인 press release distribution network
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.